Royce & Associates’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
74,516
+3,002
| +4% | +$67.7K | 0.02% | 619 |
|
|
2025
Q1 | $2M | Buy |
+71,514
| New | +$2M | 0.02% | 586 |
|
|
2018
Q4 | – | Sell |
-39
| Closed | -$18K | – | 1207 |
|
|
2018
Q3 | $18K | Buy |
39
+17
| +77% | +$7.85K | ﹤0.01% | 1159 |
|
|
2018
Q2 | $9K | Buy |
22
+15
| +214% | +$6.14K | ﹤0.01% | 1206 |
|
|
2018
Q1 | $4K | Sell |
7
-2
| -22% | -$1.14K | ﹤0.01% | 1247 |
|
|
2017
Q4 | $6K | Buy |
+9
| New | +$6K | ﹤0.01% | 1232 |
|